Candriam Equities L Biotech.I EUR Acc/ LU1120766032 /
| NAV2024-06-07 | Chg.+2.3501 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,249.3101EUR | +0.10% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 2024-06-10 | Public WebStation Live Factsheet | 2024 | English | - |
| 2024-06-03 | Prospectus | 2024 | English | 3,663.84 KB |
| 2024-06-03 | Prospectus | 2024 | German | 5,520.88 KB |
| 2024-03-01 | PRIIP Key Information Document | 2024 | English | 261.06 KB |
| 2024-03-01 | PRIIP Key Information Document | 2024 | German | 269.23 KB |
| 2023-12-31 | Account statment | 2023 | English | 5,416.37 KB |
| 2023-12-31 | Account statment | 2023 | German | 4,732.66 KB |
| 2023-06-30 | Semi-annual report | 2023 | English | 1,982.78 KB |
| 2023-06-30 | Semi-annual report | 2023 | German | 2,086.39 KB |
| 2022-07-02 | Key Investor Information | 2022 | English | 359.29 KB |
| 2022-07-02 | Key Investor Information | 2022 | German | 364.56 KB |
